Monopar Therapeutics Inc.
NASDAQ:MNPRBiotechnology
Healthcare
$71.06 +2.45%
+$1.58 today
- Market cap
- $481.56M
- Beta
- 1.54
- P/E (TTM)
- -37.6
- EPS (TTM)
- -$1.76
52W Low $29.18High $105.00
Volume 0.12M
Average 0.17M
Price history
Monopar Therapeutics Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-11.84%
Period high
$123.84
Period low
$50.12
Latest
$71.06
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 8-K | Nov 12, 2026 | Nov 12, 2026 | |
| 10-Q | Nov 12, 2026 | Nov 12, 2026 | |
| 4 | Nov 4, 2026 | Nov 4, 2026 | |
| 4 | Nov 4, 2026 | Nov 4, 2026 | |
| SC 13G | Oct 27, 2026 | Oct 27, 2026 | |
| 4 | Oct 20, 2026 | Oct 20, 2026 | |
| 4 | Oct 5, 2026 | Oct 5, 2026 | |
| 4 | Oct 2, 2026 | Oct 2, 2026 | |
| 4 | Oct 2, 2026 | Oct 2, 2026 | |
| 4 | Oct 2, 2026 | Oct 2, 2026 | |
| 4 | Sep 28, 2026 | Sep 28, 2026 | |
| 4/A | Aug 28, 2026 | Aug 28, 2026 | |
| 4/A | Aug 28, 2026 | Aug 28, 2026 | |
| 4 | Aug 27, 2026 | Aug 27, 2026 | |
| 4 | Aug 27, 2026 | Aug 27, 2026 |
Competitors
Who does Monopar Therapeutics Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about MNPR's filings, answered from its disclosures.
What is the latest MNPR filing?
The latest filing shown is 10-Q dated Nov 12, 2026.
How many recent filings does MNPR have?
Intrinsic Alpha currently shows 20 recent filings for MNPR.
Continue the stock analysis
Jump to another research area for this company.